Lead the ENABLE-2 CAR T-cell trial and advance haemato-oncology research outcomes

Clinical Research Fellow - Haemato-oncology

There is an exciting opportunity for a Clinical Research Fellow post in Haemato-oncology, starting in February 2027.

This role is offered by the Malaghan Institute of Medical Research in Kelburn, Wellington; working on the Institute's established chimeric antigen receptor (CAR) T-cell programme. Currently, there is a Phase 2 CAR T-cell trial actively recruiting patients with relapsed/ refractory Large B-cell Lymphoma in Wellington, which is the day to day focus for this post. For clinical research activities, you will be seconded to the Clinical Trials Unit in Wellington Hospital, and gain hands on experience in CAR T-cell delivery, toxicity management, clinical trial conduct, and cellular therapy quality systems. As the Clinical Fellow on the ENABLE-2 CAR T-cell trial, you would gain invaluable hands on experience treating patients on a clinical trial, utilising an exciting and innovative new type of cellular immunotherapy to treat patients with Cancer. The Clinical Fellow role does not have rostered afterhours duties. Participation in other haemato-oncology research trials and in general haematology clinics is encouraged. There will be the opportunity work on the development of future CAR T-cell research trials, and to work towards a post-graduate degree qualification.

If you have completed your RACP Written and Clinical Examinations (or equivalent), you may be eligible to apply for this post.

This post is an excellent opportunity for trainees interested in applying for Advanced training in Haematology or Medical Oncology in the future. Previous Clinical Fellow's have been successful in crediting time during the fellowship towards their RACP training programme. If you know other colleagues who may be interested in this post, please forward this advert onto them.